These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 7751997)

  • 21. Influence of vitamin D on parathyroid function in the elderly.
    Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
    J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational hypercalcemia: Prevalence and biochemical profile.
    Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
    J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intramuscular cholecalciferol megadose in children with nutritional rickets.
    Bothra M; Gupta N; Jain V
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):687-92. PubMed ID: 26913455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
    Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
    Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rickets in Nigerian children: a consequence of calcium malnutrition.
    Okonofua F; Gill DS; Alabi ZO; Thomas M; Bell JL; Dandona P
    Metabolism; 1991 Feb; 40(2):209-13. PubMed ID: 1988779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
    Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
    Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: a randomized controlled trial.
    Mittal H; Rai S; Shah D; Madhu SV; Mehrotra G; Malhotra RK; Gupta P
    Indian Pediatr; 2014 Apr; 51(4):265-72. PubMed ID: 24825262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold levels of 25-hydroxyvitamin D and parathyroid hormone for impaired bone health in children with congenital ichthyosis and type IV and V skin.
    Sethuraman G; Sreenivas V; Yenamandra VK; Gupta N; Sharma VK; Marwaha RK; Bhari N; Irshad M; Kabra M; Thulkar S
    Br J Dermatol; 2015 Jan; 172(1):208-14. PubMed ID: 24864027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aetiology of nutritional rickets in rural Bangladeshi children.
    Ahmed S; Goldberg GR; Raqib R; Roy SK; Haque S; Braithwaite VS; Pettifor JM; Prentice A
    Bone; 2020 Jul; 136():115357. PubMed ID: 32276153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vitamin D deficiency rickets: single-dose therapy versus continuous therapy].
    Stögmann W; Sacher M; Blümel P; Woloszczuk W
    Padiatr Padol; 1985; 20(4):385-92. PubMed ID: 3001619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
    Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
    Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum parathyroid hormone concentrations in vitamin D deficiency rickets of infancy: effects of intravenous calcium and vitamin D.
    Fischer JA; Binswanger U; Fanconi A; Illig R; Baerlocher K; Prader A
    Horm Metab Res; 1973 Sep; 5(5):381-5. PubMed ID: 4358425
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercalciuric rickets: metabolic studies and pathophysiological considerations.
    Tieder M; Samuel R; Liberman UA; Arie R; Halabe A; Gabizon D; Maor Y; Halperin N; Capeliovitch L; Modai D
    Nephron; 1985; 39(3):194-200. PubMed ID: 2983252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.